Satisfaction on Telemedicine during the COVID-19 among diabetes type 2 what can Saudi Arabia in Makkah Al-Mukarramah do in 2022

Main Article Content

Reham Saleem Suliman Al-Ahmadi, Khaled Abdulwahab Alsaedi, MohsenahThaar Alansari, Khaled Saad Al-Thaqafi, Nawal Zamil Hamzah Albarakati, Abdullatif Adnan Abdullatif Huldar, NisreenEsaam Albaz, Turki Mohammed Abed Al-Muwallad, Abdulrhman Jameel Alfi, AbdulmonemAbdulkhair Alqurashi, KhuludKhalied Zaini, Ahlam Yahya Bakhsh, Aishah Gali Alotibi, AbdlrhmanMostfaa Linga

Abstract

Background:


The importance of telemedicine in diabetes care became more evident during the coronavirus disease 2019 (COVID-19) pandemic as many people with diabetes, especially those in areas without well-established telemedicine, lost access to their health care providers (HCPs) during this pandemic.The importance of telemedicine in diabetes care became more evident during the coronavirus disease 2019 (COVID-19) pandemic as many people with diabetes, especially those in areas without well-established telemedicine, lost access to their health care providers (HCPs) during this pandemic.While telemedicine has several advantages, such as accessibility and cost-effectiveness, its diagnostic reliability should be further investigated. The Saudi Vision (2030) has drawn up a roadmap to invest in digital healthcare during the coming decade; however, some barriers related to using telemedicine in Saudi healthcare settings, including cultural issues and technical difficulties, should be openly discussed. In addition, before putting telemedicine in practice on a wide scale in Saudi Arabia, more efforts should be carried out to issue updated legislation and regulations, discuss and respond to ethical concerns, and ensure data security.


Aim of the study: To assessment the Satisfaction on Telemedicine during the COVID-19 among diabetes Type 2 What Can Saudi Arabia in Makkah Do in 2022.


Method: cross sectional study conducted about Telemedicine during the of COVID-19 among diabetes Type 2, we searched PubMed for articles that discussed the potential uses of telemedicine during the COVID-19 pandemic among diabetes Type 2 using the search terms “Telemedicine” and “COVID-19”.Our total participants were (250) patients with Type 2 Diabetes attending a virtual integrated care clinic center


Results: distribution of the participant with satisfaction and heave a significant relation between the satisfaction and frequency while P-value<0.001 and X289.192, participant toward Satisfaction study results show the majority of participant had AverageSatisfied were(48.4%) while high satisfied were(46.4.67


Conclusion: our Diabetes Telemedicine Clinic protocol and the high satisfaction reported by patients and HCPs make it a suitable model to be adopted by clinics, especially during pandemics or disasters in resource-limited settings.This clinic model can be quickly implemented and does not require technological tools other than those available.

Article Details

How to Cite
AbdulmonemAbdulkhair Alqurashi, KhuludKhalied Zaini, Ahlam Yahya Bakhsh, Aishah Gali Alotibi, AbdlrhmanMostfaa Linga, R. S. S. A.-A. K. A. A. M. A. K. S. A.-T. N. Z. H. A. A. A. A. H. N. A. T. M. A. A.-M. A. J. A. . (2022). Satisfaction on Telemedicine during the COVID-19 among diabetes type 2 what can Saudi Arabia in Makkah Al-Mukarramah do in 2022. Annals of the Romanian Society for Cell Biology, 26(01), 3243–3261. Retrieved from https://annalsofrscb.ro/index.php/journal/article/view/11405
Section
Articles